Progression and metastasis of small cell lung carcinoma: the role of the PI3K/Akt/mTOR pathway and metabolic alterations

Small cell lung carcinoma (SCLC) is characterized by high metastatic rate and poor prognosis. The platinum-based chemotherapy still represents the backbone of the therapy; however, acquired resistance develops almost in all patients. Although SCLC has been formerly considered a homogeneous disease,...

Descripción completa

Detalles Bibliográficos
Autores principales: Krencz, Ildiko, Sztankovics, Daniel, Danko, Titanilla, Sebestyen, Anna, Khoor, Andras
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825381/
https://www.ncbi.nlm.nih.gov/pubmed/34958428
http://dx.doi.org/10.1007/s10555-021-10012-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825381/
https://www.ncbi.nlm.nih.gov/pubmed/34958428
http://dx.doi.org/10.1007/s10555-021-10012-4

Ejemplares similares